Barclays’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.35M | Buy |
|
|||||
|
2025
Q2 | $5.96M | Buy |
|
|||||
|
2025
Q1 | $3.27M | Sell |
|
|||||
|
2024
Q4 | $5.67M | Buy |
|
|||||
|
2024
Q3 | $7.45M | Buy |
|
|||||
|
2024
Q2 | $2.95M | Sell |
|
|||||
|
2024
Q1 | $3.11M | Sell |
|
|||||
|
2023
Q4 | $6.95M | Buy |
|
|||||
|
2023
Q3 | $3.44M | Buy |
|
|||||
|
2023
Q2 | $4.68M | Sell |
|
|||||
|
2023
Q1 | $15.1M | Buy |
|
|||||
|
2022
Q4 | $16.3M | Buy |
|
|||||
|
2022
Q3 | $9.99M | Sell |
|
|||||
|
2022
Q2 | $10.9M | Buy |
|
|||||
|
2022
Q1 | $1.87M | Sell |
|
|||||
|
2021
Q4 | $5.39M | Buy |
|
|||||
|
2021
Q3 | $3.58M | Buy |
|
|||||
|
2021
Q2 | $1.86M | Sell |
|
|||||
|
2021
Q1 | $5.13M | Buy |
|
|||||
|
2020
Q4 | $1.88M | Sell |
|
|||||
|
2020
Q3 | $1.03M | Sell |
|
|||||
|
2020
Q2 | $860K | Buy |
|
|||||
|
2020
Q1 | $314K | Sell |
|
|||||
|
2019
Q4 | $848K | Buy |
|
|||||
|
2019
Q3 | $681K | Buy |
|
|||||
|
2019
Q2 | $642K | Buy |
|
|||||
|
2019
Q1 | $319K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $371K | Buy |
|
|||||
|
2018
Q2 | $19K | Sell |
|
|||||
|
2018
Q1 | $65K | Buy |
|